Healthcare Services

CRISPR-Based Diagnostics Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The CRISPR-Based Diagnostics Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The crispr-based diagnostics market has seen a rapid increase in size in recent years. It is anticipated to expand from $5.1 billion in 2025 to $6.01 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.8%. The expansion observed during the historic period can be ascribed to factors such as the necessity for swift and accurate diagnostic solutions, the drawbacks of conventional molecular tests, the heightened diagnostic demand caused by the pandemic, progress in crispr detection technologies, and the academic confirmation of crispr diagnostics.

The crispr-based diagnostics market is projected to undergo substantial expansion over the upcoming years. This market is forecast to reach $11.45 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.5%. This projected growth is driven by several factors, including the proliferation of decentralized testing models, a heightened need for early disease identification, the broadening of point-of-care diagnostic capabilities, the incorporation of digital health platforms, and its increasing application in oncology and genetic screening. Key trends anticipated during this period encompass the growing acceptance of rapid molecular diagnostics, the broadening of point-of-care testing solutions, enhanced deployment in detecting infectious diseases, the incorporation of isothermal amplification techniques, and the development of personalized diagnostic uses.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20734&type=smp

What Drivers Are Influencing The CRISPR-Based Diagnostics Market?

The increasing occurrence of infectious diseases is anticipated to drive the expansion of the CRISPR-based diagnostics market in the future. Infectious diseases are ailments originating from pathogenic microbes, including bacteria, viruses, fungi, or parasites, capable of transmission between individuals directly or indirectly via tainted surfaces, food, water, or insect vectors. The frequency of infectious diseases is escalating, attributed to elements such as globalization, antibiotic resistance, climate change, urbanization, population growth, habitat destruction, and inadequate healthcare access. CRISPR-based diagnostics bolster efforts to combat infectious diseases by providing swift and precise pathogen identification, thereby enabling early diagnosis, prompt treatment, and robust containment strategies. As an illustration, in August 2024, data released by the UK Health Security Agency, a UK-based executive agency, indicated that in England, the UKHSA recorded 368 measles cases in 2023. This represents a nearly sevenfold increase compared to the 53 cases documented in 2022, with the West Midlands and London making up 44% and 33% of these cases, respectively. Consequently, the growing occurrence of infectious diseases is propelling the CRISPR-based diagnostics market.

What Major Segment Divisions Exist Within The CRISPR-Based Diagnostics Market?

The crispr-based diagnostics market covered in this report is segmented –

1) By Product: Kits, Buffer Solutions, Software, Other Products

2) By Technique: Recombinase Polymerase Amplification (RPA), Loop-Mediated Isothermal Amplification (LAMP), Other Techniques

3) By Disease: Infectious Diseases, Non-Infectious Diseases

4) By End-User: Hospitals, Diagnostic Centers, Biotechnology Companies, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits: CRISPR Detection Kits, CRISPR Amplification Kits, CRISPR-Based Assay Kits

2) By Buffer Solutions: CRISPR Reaction Buffers, CRISPR Lysis Buffers

3) By Software: CRISPR Data Analysis Software, CRISPR Design Software, CRISPR Diagnostic Platforms Software

4) By Other Products: CRISPR Enzymes, CRISPR Reagents, CRISPR-Based Probes

How Are Trends Shaping The Direction Of The CRISPR-Based Diagnostics Market?

Leading companies operating in the CRISPR-based diagnostics market are concentrating on forging strategic partnerships to improve access to rapid and accurate diagnostics through CRISPR-based point-of-care tests. These strategic partnerships represent long-term collaborations where two or more organizations share resources and expertise to achieve mutual goals and enhance their competitive advantage. For example, in August 2023, CrisprBits Private Limited, an India-based biotechnology company, announced a strategic collaboration with Molbio Diagnostics, an India-based molecular diagnostics company, specifically for the development of CRISPR-based Point-of-Care Tests (POCTs). This collaboration aims to create fast, precise, and cost-effective diagnostic tools by leveraging CRISPR technology for the detection of pathogens and genetic markers. The goal of these POCTs is to expand diagnostic accessibility in various settings, including those with limited resources, while ensuring quick and accurate disease detection. This partnership merges CrisprBits’ specialized knowledge in CRISPR-based platforms with Molbio’s manufacturing and distribution capabilities to introduce these tests to the global market.

Which Companies Are Leading Innovation In The CRISPR-Based Diagnostics Market?

Major companies operating in the crispr-based diagnostics market are Thermo Fisher Scientific Inc., Integrated DNA Technologies Inc., Molbio Diagnostics, Horizon Discovery, Synthego Corporation, Caribou Biosciences, Mammoth Biosciences, Epic Bio, VedaBio, CrisprBits, SNIPR BIOME ApS, TOLO Biotech, Intact Genomics, Agdia Inc., ToolGen Inc., Caspr Biotech, GenScript, Twist Bioscience, Revvity Discovery Limited, Danaher Corporation, Scope Biosciences, CRISPR Diagnostics, Gene Editing Institute, Aptitude Medical Systems, Qiagen, Abingdon Health

Read the full crispr-based diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/crispr-based-diagnostics-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The CRISPR-Based Diagnostics Market?

North America was the largest region in the CRISPR-based diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crispr-based diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored CRISPR-Based Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20734&type=smp

Browse Through More Reports Similar to the Global CRISPR-Based Diagnostics Market 2026, By The Business Research Company

Crispr Gene Editing Global Market Report

https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

Crispr And Cas Gene Global Market Report

https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report

Plant Breeding And Crispr Plants Global Market Report

https://www.thebusinessresearchcompany.com/report/plant-breeding-and-crispr-plants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795